Skip to search formSkip to main contentSkip to account menu

styrenesulfonic acid polymer

Known as: poly(P-styrenesulfonic acid), P-styrenesulfonic acid polymer, poly(4-styrenesulfonic acid) 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

PolymersSulfonic Acids

Narrower (1)

poly(sodium-4-styrenesulfonate)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Design of hydrogels to stabilize and enhance bone morphogenetic protein activity by heparin mimetics.
Review
2018
Review
2018
Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis.
Review
2016
Review
2016
Luminal Toxin-Binding Agents for Clostridium difficile Infection
Objective: To systematically search the literature for trials evaluating luminal toxin-binding agents (LTBAs) for Clostridium… 
2014
2014
Editorial Commentary: the trials and tribulations of treating Clostridium difficile infection-one step backward, one step forward, but still progress.
Almost a decade ago, an editorial discussing the evidence concerning whether metronidazole was as efficacious as vancomycin for… 
2014
2014
Proton Conductance at Elevated Temperature: Formulation and Investigation of Poly(4-Styrenesulfonic Acid)/4-Aminobenzylamine/Phosphoric Acid Membranes
4-aminobenzylamine and phosphoric acid were blended in various proportions with poly (4-styrenesulfonic acid) to form a new group… 
2014
2014
Proton conductance at elevated temperature: formulation and investigation of poly(4-styrenesulfonic acid)/4-aminobenzylamine/phosphoric acid membranes
4-Aminobenzylamine (ABA) and phosphoric acid (PA) were blended in various proportions with poly(4-styrenesulfonic acid) (PSSA) to… 
Review
2008
Review
2008
Tolevamer, an orally administered, toxin-binding polymer for Clostridium difficile-associated diarrhea.
Genzyme Corp is developing tolevamer, an anionic toxin-binding polymer that binds and neutralizes the Clostridium difficile A and… 
Review
2006
Review
2006
Review article: tolevamer, a novel toxin‐binding polymer: overview of preclinical pharmacology and physicochemical properties
Background  Tolevamer is a novel toxin‐binding polymer that is currently being investigated in clinical trials for the treatment… 
2004
2004
Toxin binding of tolevamer, a polyanionic drug that protects against antibiotic-associated diarrhea.
Tolevamer, (GT160-246), is a sodium salt of styrene sulfonate polymer that is under development for the treatment of diarrhea… 
Highly Cited
1992
Highly Cited
1992
Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)